Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ProShares Ultra QQQ ETF (QLD) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance

ProShares Ultra QQQ ETFTrade
uniQure N.V. Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

ProShares Ultra QQQ ETF vs uniQure N.V. Ordinary Shares — how do they compare? ProShares Ultra QQQ ETF trades at $90.8 (market cap $15.24B), while uniQure N.V. Ordinary Shares trades at $20.78 (market cap $1.48B). The key difference: ProShares Ultra QQQ ETF is far larger — about 10.3× uniQure N.V. Ordinary Shares's market cap, and ProShares Ultra QQQ ETF is trading nearer its 52-week high, uniQure N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ProShares Ultra QQQ ETF for 36 Days and uniQure N.V. Ordinary Shares for 0 Days on average.

QLDQURE
Market Cap
$15.24B$1.48B
Volume
2,898,7062,488,780
Sector
Leveraged / InverseHealth
52-Week High
$100.77$70.59
52-Week Low
$57.16$9.03
Typical Hold Time
36 Days0 Days
Enterprise Value
—$728.62M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ProShares Ultra QQQ ETF

QLD (ProShares Ultra QQQ ETF) trades at $96.42, down 0.68% on the day, with technical indicators showing a bullish bias from moving averages while oscillators remain neutral. The ETF provides 2x leveraged exposure to the Nasdaq-100 index, positioning it as a less volatile alternative to triple-leveraged products during market downturns. Recent institutional buying by 180 Wealth Advisors LLC increased their position by 29.4% in Q2 2026, signaling confidence in the fund's strategy.

The outlook for QLD remains tied to Nasdaq-100 performance, with technical support at $95-$97 and resistance at $98-$99. While leveraged ETFs offer amplified returns, they carry elevated risk from daily rebalancing and market volatility. Investors should monitor Fed policy impacts and tech sector momentum for directional cues, with the current setup favoring tactical positions above key support levels.

uniQure N.V. Ordinary Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

QLD
100% Buy0% Sell
Avg holding period · 36 Days
QURE
100% Buy0% Sell
Avg holding period · 0 Days

About ProShares Ultra QQQ ETF

QLD is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the NASDAQ-100 Index. It achieves 2x leverage by investing in financial instruments such as swaps and is designed as a tactical trading tool for investors with a bullish (long) view on the NASDAQ-100. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.

Read more on QLD →

About uniQure N.V. Ordinary Shares

uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.

Read more on QURE →